US FDA expands use of Regeneron's cholesterol drug in young children
- Location: Ex31 4zj, Woodburn, Sydney, France
March 22 (Reuters) - Regeneron Pharmaceuticals Inc said on Wednesday the U.S.
Food and Drug Administration had approved the expanded use of its drug in children aged 5 to 11 years to treat an ultra-rare disease that causes high cholesterol.
BRUSSELS, March 20 (Reuters) - European Union member states have agreed to supply one million rounds of artillery ammunition to Ukraine, Estonian Defence Minister Hanno Pevkur said on the sidelines of a meeting with his EU counterparts in Brussels on Monday.
The drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients aged 12 years and above with homozygous familial hypercholesterolemia (HoFH).
Related listings
-
Winning Big: Online Casino Real Money94.00 Pound £Animals Alofau (Sydney) November 9, 2024Besides money prizes, many tournaments feature extra incentives such as bonuses, free spins, or 카지노친구 unique merchandise. Casinos usually make use of inventive approaches to boost the reward system, Read More igniting additional interest and motivati...
-
Exploring VIP Casino Programs178.00 US$Animals Rzeszow (Sydney) November 9, 2024Additionally, online scratch playing cards regularly come with bonuses and promotions that aren't available with conventional cards. Many platforms provide welcome bonuses for model spanking new players, loyalty rewards, or seasonal promotions that i...
-
No Deposit Casino Bonuses Explained68.00 ₹Animals Ichinoseki (Sydney) November 9, 2024Loyalty bonuses reward present players for their continued patronage, often offered as incentives for regular play. These bonuses can play a significant function in maintaining participant engagement and enhancing the gaming expertise. However, land-...